Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response
Kazuma Kiyotani(National Institute of Biomedical Innovation, Health and Nutrition), Hitoshi Zembutsu, Naoya Hosono, Tatsuhiko Tsunoda(University of California San Diego), Fuminori Aki(PharmacoGenetics (China)), Koichi Hirata(Kyushu University), Shozo Ohsumi(Shikoku Cancer Center), Michiaki Kubo(RIKEN Center for Integrative Medical Sciences), Taisei Mushiroda(RIKEN Center for Integrative Medical Sciences), Takashi Yamakawa(PharmacoGenetics (China)), Yutaka Okazaki(PharmacoGenetics (China)), Yusuke Nakamura(Rissho University), M. Okazaki(PharmacoGenetics (China)), Yuichi Takatsuka(PharmacoGenetics (China)), Mitsunori Sasa(Tokushima Breast Care Clinic)
Cited by 42
Related Papers
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
A cross-population atlas of genetic associations for 220 human phenotypes
|Nature Genetics|2021|2.4k
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
|Nature Genetics|2009|1.3k